GWAS |
- Apolipoprotein A1 levels ( 32203549)
- Basal cell carcinoma ( 31174203)
- Body mass index ( 26426971)
- Coronary artery disease ( 29212778)
- Keratinocyte cancer (MTAG) ( 31174203)
- LDL cholesterol levels ( 32203549)
- Medication use (agents acting on the renin-angiotensin system) ( 31015401)
- Red cell distribution width ( 27863252)
|
- Asthma ( 32296059)
- Bacteremia ( 27236921)
- Blood protein levels ( 28240269)
- Body fat distribution (arm fat ratio) ( 30664634)
- Body fat distribution (trunk fat ratio) ( 30664634)
- Body fat mass ( 28552196)
- Brain morphology (min-P) ( 32665545)
- Brain morphology (MOSTest) ( 32665545)
- Cholangiocarcinoma in primary sclerosing cholangitis (time to event) ( 28779025)
- Cocaine dependence ( 31212010)
- Colorectal cancer ( 29228715)
- Cortical surface area (MOSTest) ( 32665545)
- Depressive symptom (appetite changes) (binary trait) ( 31530331)
- Depressive symptoms (binary sum-score) ( 31530331)
- Depressive symptoms (sum-score) ( 31530331)
- Eosinophil counts ( 32888494 27863252)
- Eosinophil percentage of granulocytes ( 27863252)
- Eosinophil percentage of white cells ( 32888494 27863252)
- Estimated glomerular filtration rate ( 31152163)
- Height ( 20881960 25282103)
- Melanoma ( 24980573)
- Morning person ( 30696823)
- Refractive error ( 32231278)
- Subcortical volume (min-P) ( 32665545)
- Subcortical volume (MOSTest) ( 32665545)
- Sum eosinophil basophil counts ( 27863252)
- Trunk fat mass ( 28552196)
- Waist circumference adjusted for BMI (adjusted for smoking behaviour) ( 28443625)
- Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction) ( 28443625)
- Waist circumference adjusted for BMI in non-smokers ( 28443625)
|